Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
HER2 Expression in Urothelial Carcinoma (UC)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health Outcomes
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Hospital Benin, Congo, The Democratic Republic
Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid Arthritis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2025 Rheumatology Fellowship – United States
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Invasive Mold Diseases (IMD) & Treatment Outcomes
Release Date:
Review Process: Pfizer Internal
Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom
Implementing Updated RSV Immunization Recommendations for Older Adults
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Optimization of Health IT to support RSV Immunizations
Release Date:
Review Process: Expert Review Panel
Quality Improvement Vaccines USA
Title
Grant Type
Focus Area
Country
Application Due Date
Optimizing Telehealth Use in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Internal Medicine Canada
Improving ATTR Amyloidosis Management in Spain
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease Spain
Equity in Access to Rare Disease Clinical Trials
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease USA
Management of Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
2022 Inflammatory Bowel Disease (IBD) Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2022 IBD Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
Establishment of an Appropriate Network of Medical Care and Education for Axial Spondyloarthritis
Release Date:
Partner: The Japan Spondyloarthritis Society
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Japan
2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin America
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
2022 Global Hemophilia ASPIRE
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Management of Uterine Fibroids and Endometriosis
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Internal Medicine USA
2022 Fellowship for Inflammatory Dermatological Diseases
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA
2022 Rheumatology Fellowship
Release Date:
Review Process: Expert Review Panel
Fellowship Inflammation & Immunology USA